Quantum dots (QDs) restrain human cervical carcinoma HeLa cell proliferation through inhibition of the ROCK-c-Myc signaling.
Cancers often cause significant morbidity and even death to patients. To date, conventional therapies, such as chemotherapy, radiation and surgery, are often limited; meanwhile, novel anticancer therapeutics are urgently needed to improve clinical treatments. Rapid application of nanotechnology and nanomaterials represents a promising vista for the development of anti-cancer therapeutics. However, how to integrate the novel properties of nanotechnology and nanomaterials into cancer treatment warrants close investigation. In the current study, we report a novel finding about the inhibitory effect of CdSe quantum dots (QDs) on Rho-associated kinase (ROCK) activity in cervical carcinoma HeLa cells associated with the attenuation of the ROCK-c-Myc signaling. We mechanistically demonstrated that QD-conducted ROCK inhibition greatly diminished c-Myc protein stability due to reduced phosphorylation, and also suppressed its activity in transcribing target genes (e.g. HSPC111). Thus, the treatment of QDs greatly restrained HeLa cell growth by inducing cell cycle arrest at G1 phase due to the reduced ability of c-Myc in driving cell proliferation. Additionally, since HSPC111, one of the c-Myc targets, is involved in regulating cell growth through ribosomal biogenesis and assembly, the downregulation of HSPC111 could also contribute to diminished proliferation in HeLa cells upon QD treatment. These results together suggested that inhibition of ROCK activity or ROCK-mediated c-Myc signaling in tumor cells upon QD treatment might represent a promising strategy to restrain tumor progression for human cervical carcinoma.
College of Environment and Resource, Shanxi University, Taiyuan, Shanxi 030006, China.
Liqun
L
Chen
Guangbo
G
Qu
Changwen
C
Zhang
Shuping
S
Zhang
Jiuyang
J
He
Nan
N
Sang
Sijin
S
Liu
D019187:Cadmium Compounds / Q000494:pharmacology; D002277:Carcinoma / Q000378:metabolism; D016923:Cell Death; D049109:Cell Proliferation; D018450:Disease Progression; D005260:Female; D005434:Flow Cytometry; D006367:HeLa Cells; D006801:Humans; D018613:Microscopy, Confocal / Q000379:methods; D008954:Models, Biological; D010766:Phosphorylation; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism*; D045663:Quantum Dots; D012270:Ribosomes / Q000378:metabolism; D018036:Selenium Compounds / Q000494:pharmacology; D015398:Signal Transduction; D002583:Uterine Cervical Neoplasms / Q000378:metabolism; D054460:rho-Associated Kinases / Q000378:metabolism*
D019187:Cadmium Compounds; D016271:Proto-Oncogene Proteins c-myc; D018036:Selenium Compounds; C058667:cadmium selenide; D054460:rho-Associated Kinases